Data from Taiwan’s National Health Insurance database, which encompassed over 8000 cancer cases in T2DM patients, demonstrated that insulin use was linked to the highest overall cancer risk, followed by glinides and SUs. Here, INS is linked to type 2 diabetes mellitus.